Search

everythinglearnresearchcommunity

for

Search:↓

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Honokiol from Magnolia plants may be beneficial for treating various skin conditions and promoting hair growth.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Somatostatin may help protect hair follicles from immune attacks.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair loss treatment caused more hair loss in a man.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Low vitamin D levels are common in people with Alopecia Areata.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.